EVs (tumor-derived biomarkers), HIF-1α (hypoxia and angiogenesis biomarkers), and serum amyloid A (acute-phase reactants) are the foremost key biomarkers in CAS, which are involved in coagulation, inflammation, angiogenesis, vascular remodeling, and oxidative stress. Here, HIF1A is linked to neoplasm.